Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
State Street Health Care Select Sector SPDR ETF
XLV
Market cap
$38.9B
Overview
Fund Trends
Analyst Outlook
Journalist POV
148.83
USD
+0.86
0.58%
At close
Updated
Apr 14, 4:00 PM EDT
Pre-market
After hours
148.97
+0.14
0.09%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
0.58%
5 days
0.43%
1 month
-1.44%
3 months
-5.72%
6 months
4.56%
Year to date
-4.3%
1 year
7.43%
5 years
25.54%
10 years
112.4%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
39.1%
Negative
Positive
Neutral
Negative
Positive
ETF Trends
6 hours ago
What Johnson & Johnson Earnings Signal for Healthcare ETFs
With Q1 earnings season well underway, it was Johnson & Johnson (JNJ) giving investors a peek at how the broader healthcare sector might perform. The healthcare giant beat expectations on Tuesday in revenue ($24.1 billion actual versus $23.6 expected) and earnings per share ($2.70 actual versus $2.66 expected).
Neutral
Seeking Alpha
3 days ago
Can Forgotten Biotech Break Out?
After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Biotech hasn't garnered much attention lately, with all the coverage of the Iran War and the AI Doom trade that's been taking down software stocks even as AI infrastructure stocks continue to surge.
Positive
Zacks Investment Research
8 days ago
Likely Sector ETF & Stock Winners From March Jobs Report
March jobs data highlights sector winners -- Healthcare, Transport & Construction ETFs gain as hiring rebounds and steady demand supports growth.
Neutral
Zacks Investment Research
13 days ago
Consumer Sentiment Weakens: ETFs That Are Worth a Look
Rising oil prices and Middle East tensions are squeezing household finances and weakening consumer sentiment, steering investors toward defensive ETFs.
Neutral
Schwab Network
20 days ago
The Big 3: XLV, BA, SAP
Traders "live for days like these," says @Theotrade's Don Kaufman in referencing Wednesday's volatility. He offers a trio of example options trades he sees as opportunities in the price action.
Negative
Zacks Investment Research
21 days ago
Stagflation Scare? ETFs May Help Protect Your Portfolio
Are stagflation risks returning as oil-driven inflation rises amid Middle East tensions? Here's how ETFs can help defend portfolios.
Neutral
Investopedia
29 days ago
The Stocks Goldman Sachs Thinks You Should Own as Iran War Stretches Into a Third Week
The war in Iran is entering its third week with no end in sight. That, according to Goldman Sachs analysts, warrants some portfolio changes.
Negative
Zacks Investment Research
29 days ago
Middle East Turmoil and U.S. Debt Surge: ETFs in Focus
With U.S. budget deficits and already elevated debt, the ongoing Middle East war could worsen the fiscal outlook, making defensive ETF strategies worth considering for stability.
Positive
CNBC Television
1 month ago
Health care and industrials are the sectors to put money to work: Crossmark's Victoria Fernandez
Victoria Fernandez, Crossmark Global Investments, joins 'Closing Bell' to discuss the recent price action in oil, the strength in tech stocks and more.
Positive
Seeking Alpha
1 month ago
7 High-Yield CEFs That Have Never Cut The Distribution In 10 Years Plus
Guggenheim Strategic Opportunities Fund and six other CEFs have never cut distributions since inception, providing reliable monthly income for compounding portfolios. PIMCO funds PDI and PCN, along with utility-focused UTG and DNP, have weathered major market downturns while maintaining or increasing distributions. Healthcare CEFs THW and THQ offer double-digit yields and have preserved or raised distributions for at least a decade, supporting steady income streams.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close